Experience

Genedata

• Switzerland
• Biotechnology Research
• 200 - 300 Employee

• Team Manager

  • Aug 2022 - Present

• Scientific Consultant

  • Sep 2020 - Present

  – Provide expert consultation for pharma/biotech clients on digitalization and workflow selection – Identify potential BD opportunities and licensing partners for novel technologies (e.g., mRNA, vaccines, BiTE, LNP)– Manage service projects from inception to completion with highest quality of implementation and adherence to budget



Roivant Sciences

• United States
• Biotechnology
• 100 - 200 Employee

• Scientific Consultant

  • Jun 2020 - Sep 2020

  - Performed comprehensive due diligences on more than 20 assets. Provided executive summary with unique perspectives including pipeline innovation, competitor profile and customer segmentation. -Reported directly to the VP of Roivant BD corporate team and presented potential investment opportunities for first in class or best in class assets including both biologics and SME (small molecular entities). Conducted expert interviews with key opinion leaders and summarized reports of findings for actionable opportunities. -Collaborated with cross-functional team members and experts to evaluate both pre-clinical and clinical data for validation of scientific hypotheses. -Conducting proprietary researches evaluating assets that are at late clinical trial stage by analyzing the competitive landscape, industry news and company filings Show less



FundRx

• United States
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Venture Fellow

  • Jun 2019 - Jul 2020

  – Supported pre-seed and seed stage startup companies for venture capital investments – Worked with a global network of doctorates to conduct data analysis and market sizing on 3 due diligence projects – Supported pre-seed and seed stage startup companies for venture capital investments – Worked with a global network of doctorates to conduct data analysis and market sizing on 3 due diligence projects



G51

• United States
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• G51 Venture Fellow

  • Jan 2020 - Jun 2020

  – Provided scientific advice to support the business development of early stage startups – Collaborated with cross-functional team members and experts to evaluate both pre-clinical and clinical data for validation of scientific hypotheses in the medical device field – Evaluated clinical assets to support deal flow by assessing competitive landscapes, industry news and company filings – Provided scientific advice to support the business development of early stage startups – Collaborated with cross-functional team members and experts to evaluate both pre-clinical and clinical data for validation of scientific hypotheses in the medical device field – Evaluated clinical assets to support deal flow by assessing competitive landscapes, industry news and company filings



GSK

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Scientist

  • Jul 2012 - Jul 2013

  – Supported the provision of PI4KIII-β candidate compounds for oral administration; delivered more than fifty new compounds strategically designed through diversified organic synthetic pathways. – Supported multiple projects to identify nucleoside analogue pro-drugs with high potency to treat respiratory syncytial virus. – Optimized scale-up production and delivered grams-scale of selected candidates for in vivo efficacy and toxicity studies. – Worked with scientists across different disciplines, including medicine, pharmacy and biology, to investigate mechanism of action (MOA) for compound candidates. – Collaborated across different teams and functional units to support research of HCV therapeutic candidates. – Prepared reports and presented findings regularly to department heads and team leaders. Show less



Sci Pharmtech Inc

• 1 - 100 Employee

• Principle Scientist

  • Sep 2008 - Jul 2011

  – Contributed to the discovery of a patented anti-depression drug, Cymbalta (Duloxetine HCl), by screening catalysts for asymmetric hydrogenation. The challenging high-pressure hydrogenation process is in mass production now. – Oversaw the characterization and synthesis of all possible side-products generated during the production process of Valproic acid to assess potential gene-toxicity. – Developed strategies to deliver technical supplies and manufacturing supports for customer demands and operation requirement ensuring ICH guidelines and GMP are met. Show less